Guggenheim Capital’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.11M | Sell |
36,144
-2,098
| -5% | -$184K | 0.02% | 596 |
|
|
2026
Q1 | $3.46M | Sell |
38,242
-9,219
| -19% | -$846K | 0.03% | 534 |
|
|
2025
Q4 | $4.27M | Sell |
47,461
-701
| -1% | -$66.5K | 0.03% | 474 |
|
|
2025
Q3 | $4.74M | Sell |
48,162
-4,801
| -9% | -$476K | 0.03% | 462 |
|
|
2025
Q2 | $4.83M | Buy |
52,963
+1,362
| +3% | +$132K | 0.04% | 432 |
|
|
2025
Q1 | $5.84M | Buy |
51,601
+8,566
| +20% | +$916K | 0.05% | 383 |
|
|
2024
Q4 | $4.55M | Buy |
43,035
+899
| +2% | +$96.5K | 0.04% | 447 |
|
|
2024
Q3 | $4.55M | Sell |
42,136
-2,968
| -7% | -$324K | 0.03% | 564 |
|
|
2024
Q2 | $4.9M | Buy |
45,104
+5,334
| +13% | +$629K | 0.03% | 526 |
|
|
2024
Q1 | $5.25M | Sell |
39,770
-2,239
| -5% | -$280K | 0.04% | 538 |
|
|
2023
Q4 | $5.11M | Buy |
42,009
+1,480
| +4% | +$165K | 0.04% | 521 |
|
|
2023
Q3 | $4.55M | Sell |
40,529
-9,836
| -20% | -$1.25M | 0.04% | 516 |
|
|
2023
Q2 | $7.33M | Sell |
50,365
-2,957
| -6% | -$402K | 0.06% | 398 |
|
|
2023
Q1 | $6.89M | Sell |
53,322
-1,015
| -2% | -$127K | 0.06% | 408 |
|
|
2022
Q4 | $6.93M | Sell |
54,337
-3,033
| -5% | -$352K | 0.06% | 406 |
|
|
2022
Q3 | $6M | Buy |
57,370
+10,765
| +23% | +$1.18M | 0.05% | 433 |
|
|
2022
Q2 | $4.9M | Sell |
46,605
-7,134
| -13% | -$846K | 0.04% | 547 |
|
|
2022
Q1 | $6.87M | Buy |
53,739
+6,457
| +14% | +$778K | 0.04% | 531 |
|
|
2021
Q4 | $5.83M | Sell |
47,282
-2,767
| -6% | -$362K | 0.03% | 625 |
|
|
2021
Q3 | $7.11M | Buy |
50,049
+596
| +1% | +$87.7K | 0.04% | 517 |
|
|
2021
Q2 | $7.72M | Buy |
49,453
+1,227
| +3% | +$199K | 0.05% | 488 |
|
|
2021
Q1 | $7.5M | Buy |
48,226
+295
| +0.6% | +$45.7K | 0.05% | 461 |
|
|
2020
Q4 | $7.17M | Buy |
47,931
+2,959
| +7% | +$418K | 0.05% | 442 |
|
|
2020
Q3 | $5.94M | Sell |
44,972
-3,491
| -7% | -$456K | 0.04% | 454 |
|
|
2020
Q2 | $5.62M | Buy |
48,463
+6,350
| +15% | +$732K | 0.04% | 474 |
|
|
2020
Q1 | $4.13M | Sell |
42,113
-20,693
| -33% | -$2.71M | 0.04% | 512 |
|
|
2019
Q4 | $9.13M | Sell |
62,806
-11,936
| -16% | -$1.65M | 0.07% | 354 |
|
|
2019
Q3 | $9.96M | Sell |
74,742
-4,922
| -6% | -$636K | 0.08% | 315 |
|
|
2019
Q2 | $9.11M | Sell |
79,664
-1,903
| -2% | -$223K | 0.07% | 322 |
|
|
2019
Q1 | $10.1M | Buy |
81,567
+23,896
| +41% | +$2.72M | 0.08% | 282 |
|
|
2018
Q4 | $5.81M | Sell |
57,671
-6,176
| -10% | -$695K | 0.05% | 488 |
|
|
2018
Q3 | $8.15M | Sell |
63,847
-16,545
| -21% | -$1.97M | 0.05% | 448 |
|
|
2018
Q2 | $8.7M | Sell |
80,392
-371,468
| -82% | -$40.4M | 0.06% | 389 |
|
|
2018
Q1 | $47.8M | Sell |
451,860
-20,390
| -4% | -$2.37M | 0.12% | 348 |
|
|
2017
Q4 | $55.3M | Buy |
472,250
+60,709
| +15% | +$6.86M | 0.13% | 280 |
|
|
2017
Q3 | $46.8M | Buy |
411,541
+28,445
| +7% | +$3.28M | 0.11% | 341 |
|
|
2017
Q2 | $47.8M | Buy |
383,096
+6,642
| +2% | +$787K | 0.13% | 323 |
|
|
2017
Q1 | $44.6M | Sell |
376,454
-25,943
| -6% | -$2.94M | 0.12% | 343 |
|
|
2016
Q4 | $40.3M | Buy |
402,397
+88,092
| +28% | +$9.44M | 0.12% | 356 |
|
|
2016
Q3 | $39.7M | Sell |
314,305
-5,428
| -2% | -$671K | 0.12% | 288 |
|
|
2016
Q2 | $37.4M | Sell |
319,733
-25,205
| -7% | -$2.85M | 0.12% | 300 |
|
|
2016
Q1 | $35.7M | Sell |
344,938
-64,476
| -16% | -$6.24M | 0.11% | 301 |
|
|
2015
Q4 | $40.8M | Sell |
409,414
-20,812
| -5% | -$2.04M | 0.12% | 266 |
|
|
2015
Q3 | $39.2M | Sell |
430,226
-21,096
| -5% | -$2.11M | 0.12% | 253 |
|
|
2015
Q2 | $47.9M | Buy |
451,322
+31,383
| +7% | +$3.47M | 0.12% | 251 |
|
|
2015
Q1 | $47.9M | Buy |
419,939
+48,335
| +13% | +$5.51M | 0.11% | 280 |
|
|
2014
Q4 | $40.9M | Buy |
371,604
+34,198
| +10% | +$3.6M | 0.1% | 338 |
|
|
2014
Q3 | $32.9M | Buy |
337,406
+118,657
| +54% | +$11.7M | 0.08% | 430 |
|
|
2014
Q2 | $22.1M | Sell |
218,749
-3,791
| -2% | -$370K | 0.06% | 619 |
|
|
2014
Q1 | $20.4M | Buy |
222,540
+19,505
| +10% | +$1.8M | 0.06% | 600 |
|
|
2013
Q4 | $18.4M | Sell |
203,035
-9,626
| -5% | -$833K | 0.06% | 619 |
|
|
2013
Q3 | $17M | Buy |
212,661
+26,679
| +14% | +$2.1M | 0.06% | 562 |
|
|
2013
Q2 | $13.5M | Buy |
+185,982
| New | +$13.9M | 0.06% | 591 |
|
Other funds holding ZBH
Guggenheim Capital's ZBH Position: Q2 2026 in Review
Guggenheim Capital reduced its Zimmer Biomet (ZBH) stake by 5.5% in Q2 2026, selling an estimated $184K and leaving 36,144 shares worth $3.11M. The position accounts for 0.02% of the portfolio, ranked #596.
Guggenheim Capital first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $55.3M in Q4 2017. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Guggenheim Capital held 36,144 shares of Zimmer Biomet worth $3.11M as of Q2 2026.
- Guggenheim Capital sold 2,098 Zimmer Biomet shares in Q2 2026, an estimated $184K.
- Zimmer Biomet made up 0.02% of Guggenheim Capital's portfolio in Q2 2026, its #596 holding.
- Guggenheim Capital first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
- Guggenheim Capital's Zimmer Biomet position peaked at $55.3M in Q4 2017.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.